Zhou and co-workers [252] have reported that vitexin (Figure 3) showed a cytotoxic effect on breast, ovarian, and prostate cancer cells by inducing apoptosis with the cleavage of the PARP protein, the upregulation of Bax and downregulation of Bcl-2. The gene discussed is BCL2; the disease is prostate carcinoma.